CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

Previously, we showed that CD206-targeted liposomal delivery of co-encapsulated immunodominant myelin basic protein (MBP) sequences MBP(46–62), MBP(124–139) and MBP(147–170) (Xemys) suppressed experimental autoimmune encephalomyelitis in dark Agouti rats. The objective of this study was to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Belogurov, Alexey, Zakharov, Konstantin, Lomakin, Yakov, Surkov, Kirill, Avtushenko, Sergey, Kruglyakov, Peter, Smirnov, Ivan, Makshakov, Gleb, Lockshin, Curtis, Gregoriadis, Gregory, Genkin, Dmitry, Gabibov, Alexander, Evdoshenko, Evgeniy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081122/
https://www.ncbi.nlm.nih.gov/pubmed/27324388
http://dx.doi.org/10.1007/s13311-016-0448-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081122/
https://www.ncbi.nlm.nih.gov/pubmed/27324388
http://dx.doi.org/10.1007/s13311-016-0448-0

Ejemplares similares